Tier 3 · Filer Universe
Theriva Biologics, Inc.
TOVX · NYSE American · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$0.24
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0000894158
Liquidity rank
#5428
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | -2.08 | 2025-12-31 | 0001104659-26-026767 |
| Quarterly revenue | $300,000.00 | 2026-03-31 | 0001104659-26-055689 |
| Quarterly diluted EPS | -0.07 | 2026-06-30 | 0001104659-26-093786 |
SEC EDGAR Frames batch generated 2026-08-23T22:53:06.992Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNYSE AmericanBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames